Acurx Pharmaceuticals LLC
Price & Volume
Stats
See more52W Range | $1.32-$21 |
Market Cap | $11.1M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$5.32 |
News
See moreYahoo Finance • 24 days ago
Acurx Pharmaceuticals GAAP EPS of -$5.32
Yahoo Finance • 6 months ago
Acurx Pharmaceuticals Wins Positive Response From EMA On Ibezapolstat Use In Children
Yahoo Finance • 7 months ago
RSI Alert: Soleno Therapeutics (SLNO) Now Oversold
Yahoo Finance • 9 months ago
Acurx Pharmaceuticals shareholders approve board proposals at annual meeting
About
CEO | Mr. David P. Luci CPA, Esq., J.D. |
CFO | Mr. Robert G. Shawah CPA |
Address | 259 Liberty Avenue, Staten Island, NY, United States, 10305 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
